2seventy bio, Inc. (TSVT) Tops Q3 EPS by 36c

2seventy bio, Inc. (NASDAQ: TSVT) reported Q3 EPS of ($1.40), $0.36 better than the analyst estimate of ($1.76). Revenue for the quarter came in at $12 million versus the consensus estimate of $13.4 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Prenetics Global (PRE) Tops Q2 EPS by 18c
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14